Cargando…

Liquid marble technology to create cost-effective 3D cardiospheres as a platform for in vitro drug testing and disease modelling

Three-dimensional (3D) cell culturing has several advantages over 2D cultures. 3D cell cultures more accurately mimic the in vivo environment, which is vital to obtain reliable results in disease modelling and toxicity testing. With the introduction of the Yamanaka factors, reprogramming of somatic...

Descripción completa

Detalles Bibliográficos
Autores principales: Aalders, Jeffrey, Léger, Laurens, Tuerlings, Tim, Ledda, Sergio, van Hengel, Jolanda
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7509398/
https://www.ncbi.nlm.nih.gov/pubmed/33005571
http://dx.doi.org/10.1016/j.mex.2020.101065
_version_ 1783585586731286528
author Aalders, Jeffrey
Léger, Laurens
Tuerlings, Tim
Ledda, Sergio
van Hengel, Jolanda
author_facet Aalders, Jeffrey
Léger, Laurens
Tuerlings, Tim
Ledda, Sergio
van Hengel, Jolanda
author_sort Aalders, Jeffrey
collection PubMed
description Three-dimensional (3D) cell culturing has several advantages over 2D cultures. 3D cell cultures more accurately mimic the in vivo environment, which is vital to obtain reliable results in disease modelling and toxicity testing. With the introduction of the Yamanaka factors, reprogramming of somatic cells to induced pluripotent stem cells (iPSCs) became available. This iPSC technology provides a scalable source of differentiated cells. iPSCs can be programmed to differentiate into any cell type of the body, including cardiomyocytes. These heart-specific muscle cells, can then serve as a model for therapeutic drug screening or assay development. Current methods to achieve multicellular spheroids by 3D cell cultures, such as hanging drop and spinner flasks are expensive, time-consuming and require specialized materials and training. Hydrophobic powders can be used to create a micro environment for cell cultures, which are termed liquid marbles (LM). In this procedure we describe the first use of the LM technology for 3D culturing in vitro derived human cardiomyocytes which results in the formation of cardiospheres within 24h. The cardiospheres could be used for several in depth and high-throughput analyses.
format Online
Article
Text
id pubmed-7509398
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-75093982020-09-30 Liquid marble technology to create cost-effective 3D cardiospheres as a platform for in vitro drug testing and disease modelling Aalders, Jeffrey Léger, Laurens Tuerlings, Tim Ledda, Sergio van Hengel, Jolanda MethodsX Method Article Three-dimensional (3D) cell culturing has several advantages over 2D cultures. 3D cell cultures more accurately mimic the in vivo environment, which is vital to obtain reliable results in disease modelling and toxicity testing. With the introduction of the Yamanaka factors, reprogramming of somatic cells to induced pluripotent stem cells (iPSCs) became available. This iPSC technology provides a scalable source of differentiated cells. iPSCs can be programmed to differentiate into any cell type of the body, including cardiomyocytes. These heart-specific muscle cells, can then serve as a model for therapeutic drug screening or assay development. Current methods to achieve multicellular spheroids by 3D cell cultures, such as hanging drop and spinner flasks are expensive, time-consuming and require specialized materials and training. Hydrophobic powders can be used to create a micro environment for cell cultures, which are termed liquid marbles (LM). In this procedure we describe the first use of the LM technology for 3D culturing in vitro derived human cardiomyocytes which results in the formation of cardiospheres within 24h. The cardiospheres could be used for several in depth and high-throughput analyses. Elsevier 2020-09-12 /pmc/articles/PMC7509398/ /pubmed/33005571 http://dx.doi.org/10.1016/j.mex.2020.101065 Text en © 2020 The Authors. Published by Elsevier B.V. http://creativecommons.org/licenses/by/4.0/ This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Method Article
Aalders, Jeffrey
Léger, Laurens
Tuerlings, Tim
Ledda, Sergio
van Hengel, Jolanda
Liquid marble technology to create cost-effective 3D cardiospheres as a platform for in vitro drug testing and disease modelling
title Liquid marble technology to create cost-effective 3D cardiospheres as a platform for in vitro drug testing and disease modelling
title_full Liquid marble technology to create cost-effective 3D cardiospheres as a platform for in vitro drug testing and disease modelling
title_fullStr Liquid marble technology to create cost-effective 3D cardiospheres as a platform for in vitro drug testing and disease modelling
title_full_unstemmed Liquid marble technology to create cost-effective 3D cardiospheres as a platform for in vitro drug testing and disease modelling
title_short Liquid marble technology to create cost-effective 3D cardiospheres as a platform for in vitro drug testing and disease modelling
title_sort liquid marble technology to create cost-effective 3d cardiospheres as a platform for in vitro drug testing and disease modelling
topic Method Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7509398/
https://www.ncbi.nlm.nih.gov/pubmed/33005571
http://dx.doi.org/10.1016/j.mex.2020.101065
work_keys_str_mv AT aaldersjeffrey liquidmarbletechnologytocreatecosteffective3dcardiospheresasaplatformforinvitrodrugtestinganddiseasemodelling
AT legerlaurens liquidmarbletechnologytocreatecosteffective3dcardiospheresasaplatformforinvitrodrugtestinganddiseasemodelling
AT tuerlingstim liquidmarbletechnologytocreatecosteffective3dcardiospheresasaplatformforinvitrodrugtestinganddiseasemodelling
AT leddasergio liquidmarbletechnologytocreatecosteffective3dcardiospheresasaplatformforinvitrodrugtestinganddiseasemodelling
AT vanhengeljolanda liquidmarbletechnologytocreatecosteffective3dcardiospheresasaplatformforinvitrodrugtestinganddiseasemodelling